The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO WCGIC 2022 | Diagnostic challenges for cholangiocarcinoma
Lorenza Rimassa, MD, Humanitas University and IRCCS Humanitas Research Hospital, Milan, Italy, discusses the challenges of diagnosing bile duct cancer, including the specific challenges of intra-hepatic and extra-hepatic cholangiocarcinoma. A key challenge is the rarity of the disease, combined with the most frequent symptoms being common among many conditions, which means clinicians are unlikely to think of cholangiocarcinoma as a likely cause. Dr Rimassa also discusses the various diagnositic techniques that can be used and emphasises the importance of a multidisciplinary team during the diagnositic process. This interview took place at the European Society for Medical Oncology World Congress on Gastrointestinal Cancer (ESMO WCGIC) 2022 in Barcelona, Spain.
